Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Breast Cancer - Inflammatory

This section has been reviewed and approved by the Cancer.Net Editorial Board, 1/2013
Statistics

ON THIS PAGE: You will find information about how many people learn they have this type of cancer each year and some general survival information. Remember, survival rates depend on several factors. To see other pages in this guide, use the colored boxes on the right side of your screen, or click “Next” at the bottom.

Inflammatory breast cancer makes up 1% to 5% of all breast cancers. Because inflammatory breast cancer can grow and spread quickly, it may be advanced at the time of diagnosis and may be treated similarly to a late-stage breast cancer.

The five-year survival rate is the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases. Based on the latest available data from the National Cancer Institute, from 1988 and 2001, the five-year survival rate of people with inflammatory breast cancer was 34%. However, survival rates can vary between 11% and 49% depending on the stage, tumor grade, certain features of the cancer, and the types of treatment used.

Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of cancer in the United States each year, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with inflammatory breast cancer. Because survival statistics for inflammatory breast cancer are measured in multi-year intervals, they may not represent recent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics.

Source: National Cancer Institute

Choose “Next” (below, right) to continue reading this guide, or use the colored boxes located on the right side of your screen to visit any section.

Last Updated: 
Friday, February 14, 2014

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: